19
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the urinary bladder

, , &
Pages 275-282 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Daniele Calistri, Valentina Casadio, Sara Bravaccini, Wainer Zoli & Dino Amadori. (2012) Urinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential. Expert Review of Anticancer Therapy 12:6, pages 743-752.
Read now

Articles from other publishers (16)

Sukumar S. Sugeeta, Anand Sharma, Kenrick Ng, Arvind Nayak & Nikhil Vasdev. (2021) Biomarkers in Bladder Cancer Surveillance. Frontiers in Surgery 8.
Crossref
Kenrick Ng, Arnulf Stenzl, Anand Sharma & Nikhil Vasdev. (2021) Urinary biomarkers in bladder cancer: A review of the current landscape and future directions. Urologic Oncology: Seminars and Original Investigations 39:1, pages 41-51.
Crossref
Bert Dhondt, Jan Van Deun, Silke Vermaerke, Ario de Marco, Nicolaas Lumen, Olivier De Wever & An Hendrix. (2018) Urinary extracellular vesicle biomarkers in urological cancers: From discovery towards clinical implementation. The International Journal of Biochemistry & Cell Biology 99, pages 236-256.
Crossref
Yang Hyun Cho, Seung Il Jung & Eu Chang Hwang. 2018. Bladder Cancer. Bladder Cancer 599 612 .
Derya Tilki & Alexandre R. Zlotta. 2015. Bladder cancer. Bladder cancer 26 38 .
Derya Tilki, Maximilian Burger, Guido Dalbagni, H. Barton Grossman, Oliver W. Hakenberg, Juan Palou, Oliver Reich, Morgan Rouprêt, Shahrokh F. Shariat & Alexandre R. Zlotta. (2011) Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer. European Urology 60:3, pages 484-492.
Crossref
S. Joshi, A.K. Tiwari, B. Mondal & A. Sharma. (2011) Oncoproteomics. Clinica Chimica Acta 412:3-4, pages 217-226.
Crossref
Daher C. Chade, Shahrokh F. Shariat, Guilherme Godoy, Siegfried Meryn & Guido Dalbagni. (2009) Critical review of biomarkers for the early detection and surveillance of bladder cancer. Journal of Men's Health 6:4, pages 368-382.
Crossref
Shahrokh F ShariatJose A KaramJay D Raman. (2008) Urine cytology and urine-based markers for bladder urothelial carcinoma detection and monitoring: developments and future prospects. Biomarkers in Medicine 2:2, pages 165-180.
Crossref
Oliver W. Hakenberg, Susanne Fuessel, Katja Richter, Michael Froehner, Sven Oehlschlaeger, Peter Rathert, Axel Meye & Manfred P. Wirth. (2004) Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinoma. Urology 64:6, pages 1121-1126.
Crossref
Gilad E. Amiel, Tung Shu & Seth P. Lerner. (2004) Alternatives to cytology in the management of non-muscle invasive bladder cancer. Current Treatment Options in Oncology 5:5.
Crossref
Steven A Bogen & Seshi R Sompuram. (2004) Recent Trends and Advances in Immunodiagnostics of Solid Tumors. BioDrugs 18:6, pages 387-398.
Crossref
Michael A. Simon, Vinata B. Lokeshwar & Mark S. Soloway. (2003) Current bladder cancer tests: unnecessary or beneficial?. Critical Reviews in Oncology/Hematology 47:2, pages 91-107.
Crossref
MARTIN G. FRIEDRICH, ANGELIKA HELLSTERN, STEFAN H. HAUTMANN, MARKUS GRAEFEN, STEFAN CONRAD, EDITH HULAND & HARTWIG HULAND. (2002) Clinical use of Urinary Markers For The Detection And Prognosis Of Bladder Carcinoma:. The Journal of Urology, pages 470-474.
Crossref
Martin G. Friedrich, Angelika Hellstern, Stefan H. Hautmann, Markus Graefen, Stefan Conrad, Edith Huland & Hartwig Huland. (2002) Clinical use of Urinary Markers For The Detection And Prognosis Of Bladder Carcinoma: A Comparison Of Immunocytology With Monoclonal Antibodies Against Lewis X And 486p3/12 With The BTA STAT And NMP22 Tests. Journal of Urology 168:2, pages 470-474.
Crossref
Rosalita A. Almonte, Deanne L. Heath, John Whitehall, Miranda J. Russell, Sanjay Patole & Robert Vink. (1999) Gestational Magnesium Deficiency Is Deleterious to Fetal Outcome. Neonatology 76:1, pages 26-32.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.